Immunoglobulin response to adjuvanted-PHA/PMB2 (polyhydroxyalkanoate/P. multocida serotype B:2) vaccine

Published: 2 March 2021| Version 2 | DOI: 10.17632/dynk8rxbdd.2
Contributors:
Shazwani Mohamed,
Tan Suet May Amelia,
Kesaven Bhubalan

Description

Data on the response of immunoglubulins IgG, IgM, and IgA towards adjuvanted-PHA/PMB2 vaccine (adjuvanted-polyhydroxyalkanoate/P. multocida serotype B:2 vaccine) showed extended release and effectivity of vaccine with the use of polyhydroxyalkanoate (PHA) as an adjuvant in Sprague Dawley (SD) rats throughout an eight-week experiment. Data consists of raw and statistical analysis results on the changes in immunoglobulin concentrations (OD 450 nm) when four different treatment groups were administered intramuscular (IM) injection: 1) non-treatment as control, 2) P(3HB) adjuvant, 3) PMB2 vaccine, and 4) adjuvanted-P(3HB)/PMB2 vaccine.

Files

Steps to reproduce

Methodology will be described in detail in article.

Institutions

Universiti Malaysia Terengganu

Categories

Biomaterials, Vaccine, Biopolymer, Biopolymer Immobilization, Nanoscale Biomaterials, Veterinary Bacteriology, Animal Vaccine

License